Literature DB >> 19660545

Age-associated motor and visuo-spatial learning phenotype in Dyrk1A heterozygous mutant mice.

Glòria Arqué1, María Martínez de Lagrán, Maria L Arbonés, Mara Dierssen.   

Abstract

Dual-specificity tyrosine-regulated kinase 1A (DYRK1A) is a candidate gene for the Down syndrome neurological defects and may be involved in the progression of Alzheimer's disease. Heterozygous mice for Dyrk1A (Dyrk1A+/-) exhibit decreased brain size, motor abnormalities and cognitive deficits in the adult. However, there is no information about the mutant phenotype in old ages. Here we analyze the impact of Dyrk1A dosage reduction on motor performance and hippocampal-dependent learning and memory in aged Dyrk1A+/- mice. Whereas motor tests showed marked alterations in traction ability, prehensile reflex and balance, heterozygous mice only present a slight impairment of visuo-spatial memory even though they show a robust decrease of CA1-CA3 and dentate gyrus cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660545     DOI: 10.1016/j.nbd.2009.07.027

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  13 in total

1.  Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.

Authors:  Megan Stringer; Irushi Abeysekera; Jared Thomas; Jonathan LaCombe; Kailey Stancombe; Robert J Stewart; Karl J Dria; Joseph M Wallace; Charles R Goodlett; Randall J Roper
Journal:  Physiol Behav       Date:  2017-05-03

Review 2.  Antioxidants in Down syndrome.

Authors:  Ira T Lott
Journal:  Biochim Biophys Acta       Date:  2011-12-21

3.  The association of brain structure with gait velocity in older adults: a quantitative volumetric analysis of brain MRI.

Authors:  Ali Ezzati; Mindy J Katz; Michael L Lipton; Richard B Lipton; Joe Verghese
Journal:  Neuroradiology       Date:  2015-04-29       Impact factor: 2.804

Review 4.  Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome.

Authors:  Karen T Chang; Hyunah Ro; Wei Wang; Kyung-Tai Min
Journal:  Trends Neurosci       Date:  2013-09-25       Impact factor: 13.837

Review 5.  Prioritizing the development of mouse models for childhood brain disorders.

Authors:  Kevin K Ogden; Emin D Ozkan; Gavin Rumbaugh
Journal:  Neuropharmacology       Date:  2015-07-29       Impact factor: 5.250

6.  Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.

Authors:  B W M van Bon; B P Coe; R Bernier; C Green; J Gerdts; K Witherspoon; T Kleefstra; M H Willemsen; R Kumar; P Bosco; M Fichera; D Li; D Amaral; F Cristofoli; H Peeters; E Haan; C Romano; H C Mefford; I Scheffer; J Gecz; B B A de Vries; E E Eichler
Journal:  Mol Psychiatry       Date:  2015-02-24       Impact factor: 15.992

7.  NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.

Authors:  Georgios C Stefos; Ulf Soppa; Mara Dierssen; Walter Becker
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling.

Authors:  Jenna A Levy; Christy W LaFlamme; George Tsaprailis; Gogce Crynen; Damon T Page
Journal:  Biol Psychiatry       Date:  2021-04-08       Impact factor: 12.810

9.  Dyrk1A is dynamically expressed on subsets of motor neurons and in the neuromuscular junction: possible role in Down syndrome.

Authors:  Gloria Arque; Anna Casanovas; Mara Dierssen
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

10.  Activity-dependent facilitation of Synaptojanin and synaptic vesicle recycling by the Minibrain kinase.

Authors:  Chun-Kan Chen; Catherine Bregere; Jeremy Paluch; Jason F Lu; Dion K Dickman; Karen T Chang
Journal:  Nat Commun       Date:  2014-06-30       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.